Back to Results
First PageMeta Content
Health / Multi-drug-resistant tuberculosis / Tuberculosis treatment / Isoniazid / Extensively drug-resistant tuberculosis / Directly Observed Therapy – Short Course / Tuberculosis / Medicine / Microbiology


EMBARGOED UNTIL 12:45 Central European Time, Thursday 30 October 2014 Preliminary Data Show High Success Rate for Dramatically Shortened Multidrug-resistant TB Treatment Option Results Presented at 45th World Conference
Add to Reading List

Document Date: 2014-10-30 08:55:59


Open Document

File Size: 295,83 KB

Share Result on Facebook

City

Barcelona / Paris / /

Continent

North America / Europe / Africa / /

Country

Niger / Democratic Republic of Congo / Central African Republic / Benin / Burundi / Spain / Cameroon / /

/

IndustryTerm

healthcare workers / /

MedicalCondition

TB / resistant tuberculosis / HIV / disease / non-communicable diseases / multidrug-resistant tuberculosis / tuberculosis / /

Organization

World Health Organization / International Union Against Tuberculosis and Lung Disease / /

Person

Michael Kessler / I.D. Rusen / Katia Yezli / /

/

Position

laboratory technician / Senior Vice President for Research and Development / /

Product

isoniazid / /

Region

Latin America / Asia Pacific / East Asia / /

SocialTag